Catching HBV early can make a world of difference. Medical professionals typically use blood tests that check for signs of ...

Candidates for antiviral therapy include those who are in the immune clearance (hepatitis B e antigen [HBeAg]-positive) or reactivation (HBeAg-negative) phases. Hepatitis B & hepatocellular ...

GSK has revealed updated results from its phase 2b trial of its antisense drug for hepatitis B virus (HBV) infections, which reveal a sharp decline in the proportion of patients with undetectable ...

An antisense drug in development at GSK has shown further activity against hepatitis B virus (HBV) in a mid-stage trial, setting up a phase 3 assessment next year to see if it could offer a ...

having supported 90 Hepatitis B trials and counting, initiating 340+ sites and enrolling 5,000+ participants across all trial phases, including 65 Phase I and 25 Phase II studies. With experience ...

Gyre Therapeutics (GYRE) announced the publication of the manuscript titled “Hydronidone for the Treatment of Liver Fibrosis Associated with ...